跳至主要内容
临床试验/NCT04218370
NCT04218370已完成不适用

LIBERation From AcuTE Dialysis

University of California, San Francisco7 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2020年1月23日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
220
试验地点
7
主要终点
Proportion of patients with renal recovery at hospital discharge

研究概览

简要总结

The goal of the LIBERATE-D clinical trial is to improve outcomes for patients recovering from dialysis-requiring acute kidney injury (AKI-D). The impact of a conservative dialysis strategy compared to standard clinical practice of thrice-weekly dialysis will be examined to help generate knowledge for how to guide delivery of dialysis to facilitate renal recovery.

详细描述

Dialysis-requiring acute kidney injury (AKI-D) is a devastating complication among hospitalized patients for which there are no treatments other than supportive care. Recovery of sufficient renal function to stop dialysis is an unequivocally important clinical and patient-oriented outcome. Shortening dialysis duration and increasing the number of AKI-D patients who recover would have a major clinical, public health and cost-saving impact. However, there is currently no evidence to guide the delivery of dialysis to facilitate recovery. The investigators hypothesize that in patients who have AKI-D and who are hemodynamically stable, a conservative dialysis strategy--in which hemodialysis is not continued unless specific metabolic or clinical indications for renal replacement therapy (RRT) are present--will improve the likelihood of renal recovery compared with the current standard clinical practice of thrice-weekly intermittent dialysis. The investigators have conducted a pilot clinical trial to demonstrate the feasibility of this approach. The investigators propose here a 2-center randomized controlled trial to test a conservative dialysis strategy in a larger AKI-D population (N = 220).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •≥ 18 years of age
  • •Inpatient with AKI-D (intermittent hemodialysis or continuous renal replacement therapy received on at least one calendar day) at least partially due t acute tubular necrosis per the clinical nephrology team
  • •Hemodynamic stability: not requiring vasopressor support and with planned intermittent dialysis
  • •Baseline estimated glomerular filtration rate (eGFR) ≥ 15 mL/min/1.73 m2

排除标准

  • •Nontraditional indication for dialysis (end-stage liver disease awaiting transplantation, fulminant hepatic failure, intoxication)
  • •Complete nephrectomy as cause of AKI-D
  • •Kidney transplant during index hospitalization
  • •Dialysis > 3 months
  • •Decompensated heart failure requiring left ventricular assist device or continuous inotropic support
  • •Mechanical ventilation via endotracheal tube
  • •Hypoxemia requiring significant oxygen support: >5 liters/min via nasal cannula or equivalent via face mask/tracheostomy mask to maintain oxygen saturation > 95%, or requiring fraction of inspired oxygen >50% in patients with tracheostomy requiring invasive or non-invasive ventilation
  • •Unable to consent and no surrogate decisionmaker available
  • •Clinical team declines to allow study participation
  • •Anticipated discharge or transfer from study hospital within 48 hours

研究组 & 干预措施

Conservative

Experimental

Conservative dialysis strategy--dialysis prescribed only when specific metabolic or clinical indications are met. These indications are: blood urea nitrogen >112 mg/dL (40 mmol/L; blood potassium concentration >6 mmol/L; blood potassium concentration >5.5 mmol/L despite medical treatment; arterial blood gas pH <7.15, or in the absence of an available blood gas, serum bicarbonate <12 mmol/L, acute pulmonary edema due to fluid overload, responsible for hypoxemia requiring oxygen flow rate >5 L/min or equivalent via face mask/tracheostomy mask to maintain SpO2 >95% or requiring FiO2 >50% in patients with tracheostomy already on invasive or non-invasive mechanical ventilation and despite diuretic therapy; clinician judgement

干预措施: Dialysis (Procedure)

Conventional

Active Comparator

Thrice-weekly intermittent dialysis until pre-specified criteria for recovery are met

干预措施: Dialysis (Procedure)

结局指标

主要结局

Proportion of patients with renal recovery at hospital discharge

时间窗: Up to 14 days after hospital discharge (to allow for ascertainment of outcome at hospital discharge, which requires a period of sustained dialysis independence)

Alive and off dialysis at the time of discharge, with sustained independence from dialysis for 14 days. This outcome does not require that all 14 days of sustained independence occur in-hospital.

次要结局

  • Number of dialysis sessions/week(Up to 28 days)
  • Dialysis-free days to study day 28(Up to 28 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验